Ticker LaunchIPO · CYT
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. (CYT) priced its initial public offering on Jun 21, 2021 at $18.00 per share, within its $16.00–$18.00 range, raising $133.2M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $620.4M. Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- CYT
- Exchange
- Nasdaq Global Select
- Priced
- Jun 21, 2021
- IPO price
- $18.00
- Price range
- $16.00–$18.00
- Raised
- $133.2M
- Market cap at IPO price
- $620.4M
- First filed
- May 28, 2021
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed May 28, 2021
- Latest amendment Jun 14, 2021
- Final prospectus (424B4) Jun 21, 2021
- All filings on EDGAR CIK 1662244
Other Biotech & pharma IPOs in 2021
- Miromatrix Medical Inc.MIRO · Jun 24, 2021 · $43.2M
- iSpecimen Inc.ISPC · Jun 21, 2021
- Atai Beckley N.V.ATAI · Jun 21, 2021 · $225M
- Ambrx Biopharma Cayman, Inc.AMAM · Jun 21, 2021 · $126M
- Century Therapeutics, Inc.IPSC · Jun 21, 2021
- Lyell Immunopharma, Inc.LYEL · Jun 21, 2021 · $425M